Turk Ilac ve Serum Sanayi AS (TRILC) — Capital Reinvestment Ratio
Latest as of September 2025:
3.20x
Turk Ilac ve Serum Sanayi AS (TRILC) has a Capital Reinvestment Ratio of 3.20x as of September 2025, meaning it reinvests 3% of its operating cash flow (TL44.50 Million) in capital expenditures (TL142.42 Million). See Turk Ilac ve Serum Sanayi AS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.20x
Capex / Operating Cash Flow
Operating Cash Flow
TL44.50 Million
TRY
Capital Expenditures
TL142.42 Million
TRY
Data as of
Sep 2025
Most recent filing
Turk Ilac ve Serum Sanayi AS Capital Reinvestment Ratio (2019–2023)
This chart tracks Turk Ilac ve Serum Sanayi AS's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS (2019–2023)
Year-by-year Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS from 2019 to 2023. For live market cap and broader valuation context, see TRILC market cap.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.28x | TL408.19 Million | TL115.31 Million | ▼ -43.3% |
| 2020 | 0.50x | TL33.20 Million | TL16.54 Million | ▼ -73.4% |
| 2019 | 1.87x | TL13.32 Million | TL24.92 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow